In the chimeric protein, the exon seven of MLL is fused to exon two of MAML2. The MLL-MAML2 fusion protein contributes to carcinogenesis in AML and MDS, by disrupting the Notch signaling pathway (Nemoto et al., 2007). Here, MAML2 is linked to acute myeloid leukemia.